These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 9877489

  • 1. Improved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with CFC-beclomethasone.
    Leach CL, Davidson PJ, Boudreau RJ.
    Eur Respir J; 1998 Dec; 12(6):1346-53. PubMed ID: 9877489
    [Abstract] [Full Text] [Related]

  • 2. Lung deposition of hydrofluoroalkane-134a beclomethasone is greater than that of chlorofluorocarbon fluticasone and chlorofluorocarbon beclomethasone : a cross-over study in healthy volunteers.
    Leach CL, Davidson PJ, Hasselquist BE, Boudreau RJ.
    Chest; 2002 Aug; 122(2):510-6. PubMed ID: 12171824
    [Abstract] [Full Text] [Related]

  • 3. A pilot study to assess lung deposition of HFA-beclomethasone and CFC-beclomethasone from a pressurized metered dose inhaler with and without add-on spacers and using varying breathhold times.
    Leach CL, Colice GL.
    J Aerosol Med Pulm Drug Deliv; 2010 Dec; 23(6):355-61. PubMed ID: 20575669
    [Abstract] [Full Text] [Related]

  • 4. Effect of changing the fine particle mass of inhaled beclomethasone dipropionate on intrapulmonary deposition and pharmacokinetics.
    Seale JP, Harrison LI.
    Respir Med; 1998 Jun; 92 Suppl A():9-15. PubMed ID: 9850358
    [Abstract] [Full Text] [Related]

  • 5. Long-term safety and efficacy of a chlorofluorocarbon-free beclomethasone dipropionate extrafine aerosol.
    Fireman P, Prenner BM, Vincken W, Demedts M, Mol SJ, Cohen RM.
    Ann Allergy Asthma Immunol; 2001 May; 86(5):557-65. PubMed ID: 11379808
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Hydrofluoroalkane-134a beclomethasone dipropionate extrafine aerosol provides equivalent asthma control to chlorofluorocarbon beclomethasone dipropionate at approximately half the total daily dose.
    Davies RJ, Stampone P, O'Connor BJ.
    Respir Med; 1998 Jun; 92 Suppl A():23-31. PubMed ID: 9850360
    [Abstract] [Full Text] [Related]

  • 8. Effect of formulation parameters on hydrofluoroalkane-beclomethasone dipropionate drug deposition in humans.
    Leach C.
    J Allergy Clin Immunol; 1999 Dec; 104(6):S250-2. PubMed ID: 10588985
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Extra-fine particles improve lung delivery of inhaled steroids in infants: a study in an upper airway model.
    Janssens HM, De Jongste JC, Hop WC, Tiddens HA.
    Chest; 2003 Jun; 123(6):2083-8. PubMed ID: 12796192
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of HFA- and CFC-beclomethasone dipropionate on the bronchial response to methacholine (MCh) in mild asthma.
    Micheletto C, Guerriero M, Tognella S, Dal Negro RW.
    Respir Med; 2005 Jul; 99(7):850-5. PubMed ID: 15939246
    [Abstract] [Full Text] [Related]

  • 14. Asthma control with extrafine-particle hydrofluoroalkane-beclometasone vs. large-particle chlorofluorocarbon-beclometasone: a real-world observational study.
    Barnes N, Price D, Colice G, Chisholm A, Dorinsky P, Hillyer EV, Burden A, Lee AJ, Martin RJ, Roche N, von Ziegenweidt J, Israel E.
    Clin Exp Allergy; 2011 Nov; 41(11):1521-32. PubMed ID: 21752116
    [Abstract] [Full Text] [Related]

  • 15. Health-related quality of life in moderate asthma: 400 microg hydrofluoroalkane beclomethasone dipropionate vs 800 microg chlorofluorocarbon beclomethasone dipropionate. The Study Group.
    Juniper EF, Buist AS.
    Chest; 1999 Nov; 116(5):1297-303. PubMed ID: 10559091
    [Abstract] [Full Text] [Related]

  • 16. The delivery of chlorofluorocarbon-propelled versus hydrofluoroalkane-propelled beclomethasone dipropionate aerosol to the mechanically ventilated patient: a laboratory study.
    Mitchell JP, Nagel MW, Wiersema KJ, Doyle CC, Migounov VA.
    Respir Care; 2003 Nov; 48(11):1025-32. PubMed ID: 14585114
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Equivalence of asthma control with new CFC-free formulation HFA-134a beclomethasone dipropionate and CFC-beclomethasone dipropionate.
    Dahl R, Ringdal N, Ward SM, Stampone P, Donnell D.
    Br J Clin Pract; 1997 Nov; 51(1):11-5. PubMed ID: 9158265
    [Abstract] [Full Text] [Related]

  • 19. Safety of hydrofluoroalkane-134a beclomethasone dipropionate extrafine aerosol.
    Thompson PJ, Davies RJ, Young WF, Grossman AB, Donnell D.
    Respir Med; 1998 Jun; 92 Suppl A():33-9. PubMed ID: 9850361
    [Abstract] [Full Text] [Related]

  • 20. Growth, systemic safety, and efficacy during 1 year of asthma treatment with different beclomethasone dipropionate formulations: an open-label, randomized comparison of extrafine and conventional aerosols in children.
    Pedersen S, Warner J, Wahn U, Staab D, Le Bourgeois M, Van Essen-Zandvliet E, Arora S, Szefler SJ, Pediatric Study Group.
    Pediatrics; 2002 Jun; 109(6):e92. PubMed ID: 12042586
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.